| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 18.14 | 12.2% |
| Total Income | 18.32 | 12.1% |
| Expenditure | 16.77 | 13.6% |
| PBT | 1.55 | 6.9% |
| Net Profit | 0.97 | 12.9% |
| OPM | 12.99% | 2.71pp |
| NPM | 5.28% | 0.05pp |
| EPS | 8.06 | 12.9% |
Mercury Laboratories Ltd Reports Q3 2025 Financial Results with 13.81% Net Profit Growth
13 Aug 2025 · 13 Aug 2025, 10:36 am
Summary
Mercury Laboratories Ltd, a company in the pharmaceuticals sector, has reported its financial results for Q3 2025. The company has reported a net profit growth of 13.81% compared to the same quarter last year.
Key Highlights
- 1
Revenue from Operations for Q3 2025 is 1,813.54
- 2
Profit before Tax for Q3 2025 is 133.43
- 3
Net Profit after Tax for Q3 2025 is 69.84
- 4
Earnings Per Share for Q3 2025 is 26.21
- 5
The business of the Company fall under Single Segment i.e. 'Pharmaceuticals Products'
Management Comments
N
Name of the Management Person
Comment of the Management Person
Informational and educational content only. Not investment advice.